SoCalBio Mast
SoCalBio Weekly Update
Welcome, New SoCalBio Members
Synedgen
(Claremont)


A bio-pharmaceutical company committed to developing novel therapies to treat infections by targeting sites where bacteria enter the human body... Learn more

IntriMed Technologies (Oxnard)

SoCalBio MastIntriMed designs and manufactures ultra-precision mechanical components critical to medical device functionality... Learn more
 
West Coast Clinical Trials (Cypress)


West Coast Clinical Trials (WCCT) is a privately owned independent Phase I-IV CRO.... Learn more
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Weekly Update Sponsor
Past Weekly Updates
Recommended Events


Advance your Career

Enroll in Operations Management Certificate Program at Santiago Canyon College (City of Orange) 

Editor: Ahmed Enany
President & CEO
Southern California 
Biomedical Council
(SoCalBio)
enany@socalbio.org
www.socalbio.org
June 14, 2010

Mark Your Calendar

November 4, 2010
(with a CEO Reception & Dinner on November 3)
J W Marriott of L.A. Live

Medical Innovation
Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs and Find Cures in America

This is a recently published report by the Battelle Technology Partnership arguing that America must move forward with a dedicated and aggressive medical innovation agenda that will help get the economy back on track, facilitate the work of scientists and innovators, and bring to market products that will address some of the world's most pressing medical challenges ... Read report
MedTech Sector Analysis
State Economic Impact of the Medical Technology Industry

The Lewin Group prepared a report for AdvaMed that examined the economic impact of the medical device and in vitro diagnostics industry at the state level. The report shows that the medical technology industry is a strong and vibrant contributor to the U.S. economy, responsible in 2008 for nearly 423,000 jobs, $24.6 billion in annual payroll, and almost $136 billion worth of products sold. The industry also has a strong positive multiplier effect with each medical technology job generating on average an additional 1.5 jobs in each state ... Read report
Personalized Medicine
Digital Pathology Will Usher in a New Era of Personalized Medicine

Joseph Krueger at Seeking Alpha contends that utilizing digital pathology to develop a non-genome based companion diagnostic which can serve the majority patient population is key to making "personalized medicine" a reality... Read more
SoCalBio Golf Classic
Enjoy a Round of Golf While Supporting the Cause of Fighting Multiple Sclerosis

Reserve a playing spot now. The field is almost full

June 28, 10:00 AM - 8:30 PM

SoCalBio/Image 2000 Golf Classic
(ending with with reception and dinner)
Old Ranch Country Club in Seal Beach
Thanks to Title Sponsor

Join your medtech and biotech colleagues and friends for a great day of golf in one of the exquisite courses in Southern California while you show your support for the bioscience industry, the Multiple Sclerosis Society and SoCalBio.
RSVP for Mixers and Executive Forums
June 28, 5:00 - 8:30 PM
Post Golf Tournament Cocktail Reception and Dinner
Old Ranch Country Club in Seal Beach

Dr. Leslie Weiner
The SoCalBio/Image 2000 Golf Classic will conclude with a cocktail reception and dinner. This post-tournament mixer will feature Dr. Leslie Weiner of the USC Keck School of Medicine who will address attendees about new multiple sclerosis treatment modalities. You don't need to sign up for the tournament to be able to participate in this dinner.

RSVP to Attend the Dinner 
(Only if you are NOT a tournament player. This dinner is already included in the players' package of benefits)
 

*********************************************************
July 23, 8:00 AM to 12:00 Noon
SoCalBio Open House
Wilshire Grand Hotel in Downtown Los Angeles
 
Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.
RSVP Now
From the Lab Bench
  
Kenneth Shea, UCI Chemistry
UC Irvine Researchers Create Antibodies Made Entirely from Plastic

Antibodies made entirely from plastic have saved the lives of mice injected with bee venom - the first time such a strategy has worked in live animals. Kenneth Shea led the team at UCI which is developing the antibodies. This is the first step towards customized antibodies for a host of other medical applications, from treating people who have been poisoned to combating infection... Read more
Clinical Data
  MannKind's FREZZA Demonstrates Non-Inferiority Compared to Standard Therapy in Controlling Blood Sugar Levels in Type 1 Diabetes Patients 

MannKind Corporation announced that results of a new 16-week trial show that the investigational ultra rapid acting mealtime insulin, AFREZZA (insulin human [rDNA origin]) Inhalation Powder, combined with basal insulin, is clearly non-inferior to standard therapy insulin lispro, a rapid acting insulin, also combined with basal insulin, in reducing HbA1c levels in subjects with inadequately controlled Type 1 diabetes. .. Read more

New ABRAXANE Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma

New data on Abraxis BioScience's novel nab technology, which leverages albumin nanoparticles for the active and targeted delivery of chemotherapeutics to the tumor, has been presented at ASCO in a wide range of tumor types, including pancreatic, ovarian, breast, head and neck, and non-small cell lung cancers. The company is investigating the potential of nab-driven chemotherapy to deliver cytotoxic agents directly to the tumor microenvironment through a previously unrecognized tumor-activated, albumin-specific biologic pathway in the most difficult-to-treat cancer types, including metastatic malignant melanoma... Read more
Regulatory
ImmunoCellular Therapeutics Granted Orphan Drug Status for ICT-107 
The FDA has granted orphan drug designation for ICT-107, the company's dendritic cell-based cancer vaccine candidate which targets glioblastoma multiforme (GBM). As a result of the orphan drug status, ImmunoCellular will be eligible to receive a number of benefits, including access to grant funding for clinical trials, tax credits, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of up to seven years... Read more
 
New Products
The Northridge-Based Medtronic Diabetes Has Unveiled a New Continuous Glucose Monitor, the iPro 2

iPro 2
The device is designed for use by physicians to identify dangerous blood glucose fluctuations in diabetic patients. For now the system has the European CE mark, and it awaiting an FDA regulatory approval. Medtronic touts the system's ease of use, for example the fact that it doesn't require the patient to do anything with it beside wearing it... Read more
 
Masimo Launches Rainbow Acoustic Monitoring 


Masimo has announced the full market release of its Rainbow Acoustic Monitoring, a low-profile adhesive sensor that provides continuous and noninvasive respiration rate monitoring. The device can help clinicians detect respiratory compromise and patient distress during procedural sedations, or for continuous monitoring in ICUs or even on regular floors... 
Read more
Personnel
 Response Genetics, Inc. Announces Appointment of Michael B. McNulty as COO 

In his role as COO, Mr. McNulty brings extensive experience in managing the scale-up of laboratory operations and testing services. Most recently, Mr. McNulty was general manager, Diagnostics at Agilent Technologies, Inc., a premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis with annual net revenue of $4.5 billion ... Read more

ImmunoCellular Therapeutics Appoints Rahu Singhvi to Board of Directors

ImmunoCellular Therapeutics in Woodland Hills announced that Dr. Rahul Singhvi has been appointed to the company's Board of Directors. Dr. Singhvi is currently the President and Chief Executive Officer of Novavax, Inc. , a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide. His appointment increases the number of independent directors to five... Read more
Jobs Available
HemaCare Corp (Van Nuys) 

HemaCare provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments to patients with a variety of disorders. The company is seeking to fill the following positions:
Dentatek (Laguna Niguel)

Dentatek Corporation has a novel technology to clean root canals that promises to revolutionize endodontic therapy. The company is seeking to fill the following positions:
    • Quality Manager
    • Director of Regulatory Affairs
For more information and to apply, click here
About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio